Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Expansion From $70.96 Billion In 2026 To $121.22 Billion In 2030
The market for topical drugs contract development and manufacturing organizations (CDMOs) has experienced significant expansion in recent years. Projected to increase from $61.16 billion in 2025 to $70.96 billion in 2026, this growth reflects a compound annual growth rate (CAGR) of 16.0%. Several factors have driven this historic period of expansion, including the rise in pharmaceutical outsourcing, a growing incidence of dermatological conditions, cost-saving measures implemented by pharmaceutical firms, heightened regulatory complexities, and the broadening availability of generic topical drugs.
The contract development and manufacturing organization (CDMO) market for topical drugs is anticipated to experience rapid expansion over the coming years. By 2030, it is projected to reach $121.22 billion, growing at a compound annual growth rate (CAGR) of 14.3%. This forecast period growth is driven by the rising development of advanced topical therapies, an increased demand for transdermal patches, the expansion of pipelines among small and mid-sized pharmaceutical companies, a growing requirement for scalable manufacturing capabilities, and a heightened emphasis on accelerating time-to-market. Key trends shaping this period include a greater reliance on outsourcing for topical drug production, an escalating need for complex topical formulations, the broadening of transdermal drug delivery systems, a stronger focus on manufacturing that adheres to regulatory standards, and an increased demand for comprehensive, end-to-end CDMO solutions.
Download A Free Sample Report For Comprehensive Market Insights:
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth Momentum: Which Factors Are Influencing Demand?
The rising incidence of skin disorders is anticipated to drive the expansion of the topical drugs contract development and manufacturing organization (CDMO) market in the coming period. These medical conditions impact the skin, resulting in symptoms like inflammation, itching, and lesions. This upward trend in skin disease prevalence is influenced by environmental pollution, exposure to UV radiation, genetic factors, shifts in lifestyle, and microbial infections. Through the development and production of targeted therapies, topical drugs CDMOs play a key role in reducing skin disease prevalence by enhancing the management and treatment of dermatological issues. For example, in 2023, Cancer Australia, a government agency based in Australia, reported that around 8,257 new melanoma cases were diagnosed, representing 2.6% of all cancer-related deaths. Consequently, the growing prevalence of skin diseases is fueling growth in the topical drugs CDMO market.
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segmentation: How Is The Market Structured Across Key Categories?
The topical drugs contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders
4) By Transdermal Products: Patches
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Trends Reshaping Industry Growth
Leading firms in the topical drugs contract development and manufacturing organization (CDMO) market are prioritizing the establishment of cutting-edge production facilities to maintain their competitive edge. A state-of-the-art manufacturing facility refers to a specialized site outfitted with the newest technologies and advanced processes specifically designed for creating and producing topical pharmaceutical products. For example, in November 2023, SOHM Inc., a pharmaceutical company based in the United States, unveiled a CDMO GMP manufacturing facility. This new site in Carlsbad provides extensive space for topical product manufacturing and SOHM’s operations, featuring 2,500 square feet allocated for storing finished goods. Initially, it boasts a daily production capacity of 500 gallons (1,892 liters) for topical items. By the conclusion of Q1 2024 or the beginning of Q2 2024, the facility is anticipated to broaden its capabilities to include soft-gel suppositories.
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Leading Companies
Major companies operating in the topical drugs contract development and manufacturing organization (cdmo) market are Catalent Inc., Lonza Group AG, Recipharm AB, Piramal Pharma Solutions, Cambrex Corporation, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., MedPharm Ltd, Tergus Pharma LLC, NextPharma Technologies Holding Limited, Bora Pharmaceuticals Co. Ltd., LTS Lohmann Therapie-Systeme AG, CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., Dow Development Laboratories LLC, Tedor Pharma Inc.
Access The Complete Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report:
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Leading Geography: Which Region Generates The Most Revenue?
Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the topical drugs contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model